PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808926
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808926
Digital Health For Cardiovascular Market size was valued at US$ 42,624.29 Million in 2024, expanding at a CAGR of 22.50% from 2025 to 2032.
The Digital Health for Cardiovascular Market is a subset of healthcare that employs digital technologies such as mobile health apps, wearable devices, telemedicine, remote monitoring tools, artificial intelligence (AI), and cloud-based platforms to prevent, diagnose, monitor, and manage cardiovascular diseases. This market includes solutions that enable real-time data collection, remote patient engagement, and personalized cardiovascular care in order to improve patient outcomes, enhance clinical decision-making, and lower healthcare costs. It includes a wide range of products and services designed to treat conditions such as hypertension, arrhythmias, heart failure, and coronary artery disease using technology-driven interventions.
Digital Health For Cardiovascular Market- Market Dynamics
Surge In Cardiovascular Diseases Fuels Growth of Digital Health For Cardiovascular Market
The rising global prevalence of cardiovascular disease is expected to drive the growth of the Digital Health For Cardiovascular Market in the coming years. Cardiovascular diseases (CVDs) are conditions affecting the heart and blood vessels. It is a common term for diseases that harm the heart or blood vessels. Cardiovascular digital solutions help to promote patient autonomy by allowing patients to self-monitor health activities that reduce disease risk factors and encourage adherence to these lifestyle changes. The use of these solutions reduced the morbidity and mortality from cardiovascular diseases. As a result, the rise in cardiovascular disease cases drives up demand for cardiovascular digital solutions. For instance, in March 2024, according to data published by the Office for Health Improvement and Disparities, a UK-based government department, there were just over 1,862,500 people (3%) with a GP diagnosis of coronary heart disease in England. As a result, the global prevalence of cardiovascular disease is driving the Digital Health For Cardiovascular Market.
Digital Health For Cardiovascular Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.50% over the forecast period (2025-2032)
Based on Component segmentation, in 2025, the services segment will have the largest market share.
The provider segment held a significant market share in the end-use segment.
On the basis of region, North America generated the most revenue in 2025.
The Global Digital Health For Cardiovascular Market is segmented on the basis of Component, End-use, and Region.
The market is divided into three categories based on Component: Software, Services, and Hardware. In 2025, the services segment will account for the largest market share. Market service providers offer their solutions in both integrated packages and individual products. The growing demand for advanced software and platforms, such as Electronic Medical Records (EMRs) and Electronic Health Records (EHRs), is propelling segment expansion. For instance, in January 2024, Medtronic and Cardiac Design Labs collaborated to introduce Padma Rhythms, a new Electronic Loop Recorder (ELR) patch. Furthermore, the growing need for telehealth applications to monitor cardiovascular health in real time, rapid advancements in digital infrastructure, rising internet and smartphone penetration, and rapid development of hardware and software components are all expected to drive segment growth.
The market is divided into four categories based on End-use: Patients, Payers, Providers, and Others. The provider segment accounted for a significant market share in the end-use segment, owing to the rapid adoption of innovative technologies such as digital therapeutics and telemedicine. Healthcare providers are rapidly adopting digital solutions to deliver personalized treatment plans, remote consultations, and evidence-based therapies that go beyond traditional care. By incorporating digital tools, providers can provide more personalized and accessible care, which ultimately leads to better patient outcomes. These factors contribute to the growth of digital health in the cardiovascular market, improving patient outcomes and healthcare efficiency.
Digital Health For Cardiovascular Market- Geographical Insights
North America will dominate the overall digital health for the cardiovascular industry in 2025, owing to increased healthcare IT expenditure to support digital infrastructure, technological advancements, and supportive government initiatives. For instance, in May 2022, the American College of Cardiology published principles guidelines to support digital health initiatives and announce the most recent scientific discoveries. Furthermore, the population in North America is increasingly adopting wearable devices for health management in conjunction with telemedicine platforms. These integrated systems play a critical role in improving patient outcomes and overall community health by allowing for early intervention.
Asia Pacific is expected to have the fastest CAGR over the forecast period. The regional market is expected to grow due to increased mHealth platform adoption and healthcare expenditure in the region. Furthermore, the Asia Pacific region's industry growth is expected to be driven by technological advancements in the field as government spending on healthcare increases. The growing involvement of key market players, as well as the emergence of niche entrepreneurial ventures in Asia Pacific, have boosted regional adoption of digital apps and platforms.
The digital health for cardiovascular market is highly competitive and rapidly evolving, with key players using advanced technologies such as AI, IoT, wearable devices, and cloud-based platforms to improve cardiovascular disease management. Apple, Inc., Ultrasonics Limited, Orange Business, Siemens Healthineers AG, and Epic Systems Corporation are pioneers in remote patient monitoring, smart diagnostics, and telecardiology solutions, driving market innovation. Startups and health-tech companies such as iRhythm Technologies and AliveCor are also gaining traction for providing AI-powered ECG monitoring and arrhythmia detection. Strategic collaborations, product launches, and regulatory approvals are driving up competition, while increased investments in digital therapeutics and personalised care are reshaping the industry landscape.
In March 2024, Wellysis, a Samsung subsidiary, has collaborated with Artella Solutions (ARTELLA) to launch its remote cardiac monitoring service in the United States. This collaboration aims to provide the FDA-cleared S-Patch electrocardiogram monitoring solution from ARTELLA in ten states.